Fitzpatrick, Cella, Harper & Scinto Honored as Firm of the Year in Life Science/Biotech and Pharmaceutical IP Litigation by Managing Intellectual Property
New York, NY, April 18, 2010 --(PR.com)-- Fitzpatrick, Cella, Harper & Scinto, (www.fitzpatrickcella.com) one of the world’s premier intellectual property law firms, has been recognized by a leading international magazine for IP owners – Managing Intellectual Property (http://www.managingip.com/about) – in two categories in its recent 2010 North American Awards. Fitzpatrick received its third consecutive award from Managing IP (MIP) for the Firm of the Year in Pharmaceutical IP Litigation, as well as its first Firm of the Year award in the Life Science/Biotechnology category.
“We are honored that our firm has received these prestigious awards from MIP for our work in both Life Science/Biotechnology and Pharmaceutical IP Litigation,” said Fitzpatrick, Cella Managing Partner Colleen Tracy. “Receiving this recognition is a continued affirmation of the firm’s leadership in intellectual property practice and is a tribute to the diligence and professionalism that Fitzpatrick has come to represent.”
The awards were announced at Managing Intellectual Property’s North America Awards 2010 ceremony, held yesterday evening. As part of the selection process, MIP researchers ask for recommendations for firms that had an outstanding year in any aspect of IP work from peers and clients in 70 markets. Founded in 1990, Managing Intellectual Property is now firmly established as a leading international magazine for IP owners, with more than 8,000 readers around the globe.
Fitzpatrick is well known for its work representing many of the world's major pharmaceutical companies, including Astellas, AstraZeneca, Bausch & Lomb, Bristol-Myers Squibb, Daiichi Sankyo, Gilead, GlaxoSmithKline, Merck, Novartis, Reckitt Benckiser, Sanofi-Aventis, UCB and Warner Chilcott. The firm has litigated patents in virtually every field of medicine, including such diverse areas as anti-infectives, antipsychotics, oncologics, cardiovascular drugs, fertility control, hormone replacement, anti-ulcer drugs, anti-inflammatories, anti-epileptics and anti-virals.
About Fitzpatrick, Cella, Harper & Scinto
Fitzpatrick, Cella, Harper & Scinto, (www.fitzpatrickcella.com) founded in 1971, is a leading national intellectual property law firm of over 160 lawyers with offices in New York, Costa Mesa, California and Washington, D.C. The Firm’s practice covers the spectrum of intellectual property services, including applying for patent and trademark protection, litigation, appeals, interferences, alternative dispute resolution, licensing, opinions, corporate transactions and due diligence. Fitzpatrick represents an international client base from Fortune 500 companies to start-up companies.
###
“We are honored that our firm has received these prestigious awards from MIP for our work in both Life Science/Biotechnology and Pharmaceutical IP Litigation,” said Fitzpatrick, Cella Managing Partner Colleen Tracy. “Receiving this recognition is a continued affirmation of the firm’s leadership in intellectual property practice and is a tribute to the diligence and professionalism that Fitzpatrick has come to represent.”
The awards were announced at Managing Intellectual Property’s North America Awards 2010 ceremony, held yesterday evening. As part of the selection process, MIP researchers ask for recommendations for firms that had an outstanding year in any aspect of IP work from peers and clients in 70 markets. Founded in 1990, Managing Intellectual Property is now firmly established as a leading international magazine for IP owners, with more than 8,000 readers around the globe.
Fitzpatrick is well known for its work representing many of the world's major pharmaceutical companies, including Astellas, AstraZeneca, Bausch & Lomb, Bristol-Myers Squibb, Daiichi Sankyo, Gilead, GlaxoSmithKline, Merck, Novartis, Reckitt Benckiser, Sanofi-Aventis, UCB and Warner Chilcott. The firm has litigated patents in virtually every field of medicine, including such diverse areas as anti-infectives, antipsychotics, oncologics, cardiovascular drugs, fertility control, hormone replacement, anti-ulcer drugs, anti-inflammatories, anti-epileptics and anti-virals.
About Fitzpatrick, Cella, Harper & Scinto
Fitzpatrick, Cella, Harper & Scinto, (www.fitzpatrickcella.com) founded in 1971, is a leading national intellectual property law firm of over 160 lawyers with offices in New York, Costa Mesa, California and Washington, D.C. The Firm’s practice covers the spectrum of intellectual property services, including applying for patent and trademark protection, litigation, appeals, interferences, alternative dispute resolution, licensing, opinions, corporate transactions and due diligence. Fitzpatrick represents an international client base from Fortune 500 companies to start-up companies.
###
Contact
Valerie Capullo
2126972600
2126972600
Contact
Categories